Miguel Torralba-González

24PUBLICATIONS
108CO-AUTHORS
Traditional, complementary and integrative medicine not elsewhere classifiedPacific Peoples life coursePredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsAboriginal and Torres Strait Islander medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 17, 2026
Quality of life among older adults with HIV after switching to bictegravir-based three-drug or dolutegravir-based two-drug regimens.

|Aug 18, 2026
Patient-Reported Outcomes with Long-Acting Cabotegravir and Rilpivirine in People Living with HIV.

|Jul 25, 2026
Cumulative Metformin Use and Hepatocellular Carcinoma Risk After HCV SVR: A Multicentre Cohort Study.

|Jul 16, 2026
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

|Apr 21, 2026
Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

|Mar 26, 2026
Use of long-acting cabotegravir and rilpivirine in people living with HIV: A prospective observational cohort study.

Ana Codonal, Alicia Lázaro, Elena Martínez

Pageof 4

Frequent Collaborators

5 joint publications

Alfonso Cabello-Úbeda

5 joint publications

Pablo Martínez-Blanco

4 joint publications

Carmen Hidalgo-Tenorio

4 joint publications

Jesús Troya García